Skip to main content
. Author manuscript; available in PMC: 2019 Aug 19.
Published in final edited form as: Obesity (Silver Spring). 2015 Nov 27;24(1):148–156. doi: 10.1002/oby.21348

Fig.6.

Fig.6.

Effect of NanoSOD on genes modulating fatty acid metabolism and hepatic steatosis. Markers of fatty acid metabolism (A) were assessed in liver samples by real-time PCR. Hepatic lipid accumulation in CD (B), HF (C), and HF+Nano (D) was analyzed using hematoxylin and eosin staining, while hepatic triglycerides (E) were determined using gas chromatography. All mRNA values were normalized to 18S. Values are expressed as mean ± SEM of 10-14 samples in each group. *P<0.05 & **P<0.01 vs CD; ^P<0.05 vs HF. CD, chow diet; HF, high fat diet; and Nano, NanoSOD.